Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huaier Granules for Elevated Tumor Markers in Early-Stage Breast Cancer
NCT05871437Phase 4Not yet recruiting
- Sponsor
- Fudan University
- Start
- Sep 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of huaier granule in breast cancer (2 arms), sponsored by Fudan University. Primary endpoint: Recovery rate of any tumor marker (CEA/CA125/CA153) to normal at 2 years. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
huaier granule
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05871437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05871437.